标题
Emerging treatments for Alzheimer’s disease for non-amyloid and non-tau targets
作者
关键词
-
出版物
Expert Review of Neurotherapeutics
Volume 17, Issue 7, Pages 683-695
出版商
Informa UK Limited
发表日期
2017-05-11
DOI
10.1080/14737175.2017.1326818
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Vitamin E Paradox in Alzheimer's Disease: It Does Not Prevent Loss of Cognition and May Even Be Detrimental
- (2017) Ana Lloret et al. JOURNAL OF ALZHEIMERS DISEASE
- Reductions in Amyloid-β-Derived Neuroinflammation, with Minocycline, Restore Cognition but do not Significantly Affect Tau Hyperphosphorylation
- (2017) Anna Parachikova et al. JOURNAL OF ALZHEIMERS DISEASE
- GM-CSF Upregulated in Rheumatoid Arthritis Reverses Cognitive Impairment and Amyloidosis in Alzheimer Mice
- (2017) Tim D. Boyd et al. JOURNAL OF ALZHEIMERS DISEASE
- Fyn inhibition rescues established memory and synapse loss in Alzheimer mice
- (2015) Adam C. Kaufman et al. ANNALS OF NEUROLOGY
- The selective positive allosteric M1 muscarinic receptor modulator PQCA attenuates learning and memory deficits in the Tg2576 Alzheimer's disease mouse model
- (2015) Vanita Puri et al. BEHAVIOURAL BRAIN RESEARCH
- Investigational drugs targeting 5-HT6 receptors for the treatment of Alzheimer’s disease
- (2015) Karsten Wicke et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Progresses in treating agitation: a major clinical challenge in Alzheimer’s disease
- (2015) Francesco Panza et al. EXPERT OPINION ON PHARMACOTHERAPY
- Combination Therapy with Cholinesterase Inhibitors and Memantine for Alzheimer’s Disease: A Systematic Review and Meta-Analysis
- (2015) Shinji Matsunaga et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia
- (2015) Jeffrey L. Cummings et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- RBM3 mediates structural plasticity and protective effects of cooling in neurodegeneration
- (2015) Diego Peretti et al. NATURE
- Allopregnanolone enhances the neurogenesis of midbrain dopaminergic neurons in APPswe/PSEN1 mice
- (2015) P. Zhang et al. NEUROSCIENCE
- A Multicenter, Double-Blind, Placebo-Controlled Trial of the PDE9A Inhibitor, PF-04447943, in Alzheimer’s Disease
- (2014) Elias Schwam et al. Current Alzheimer Research
- Effect of Citalopram on Agitation in Alzheimer Disease
- (2014) Anton P. Porsteinsson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014
- (2014) L. S. Schneider et al. JOURNAL OF INTERNAL MEDICINE
- Safety and efficacy of idalopirdine, a 5-HT 6 receptor antagonist, in patients with moderate Alzheimer's disease (LADDER): a randomised, double-blind, placebo-controlled phase 2 trial
- (2014) David Wilkinson et al. LANCET NEUROLOGY
- The Evolution of Preclinical Alzheimer’s Disease: Implications for Prevention Trials
- (2014) Reisa Sperling et al. NEURON
- Amyloid-β and Tau
- (2014) George S. Bloom JAMA Neurology
- Effects of risperidone, clozapine and the 5-HT6 antagonist GSK-742457 on PCP-induced deficits in reversal learning in the two-lever operant task in male Sprague Dawley rats
- (2013) N.M.W.J. de Bruin et al. BEHAVIOURAL BRAIN RESEARCH
- Modulating nitric oxide signaling in the CNS for Alzheimer’s disease therapy
- (2013) Qin Zhihui Future Medicinal Chemistry
- Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
- (2013) Clifford R Jack et al. LANCET NEUROLOGY
- Blockade of Tau Hyperphosphorylation and Aβ1–42 Generation by the Aminotetrahydrofuran Derivative ANAVEX2-73, a Mixed Muscarinic and σ1 Receptor Agonist, in a Nontransgenic Mouse Model of Alzheimer’s Disease
- (2013) Valentine Lahmy et al. NEUROPSYCHOPHARMACOLOGY
- Mibampator (LY451395) randomized clinical trial for agitation/aggression in Alzheimer's disease
- (2012) Paula T. Trzepacz et al. INTERNATIONAL PSYCHOGERIATRICS
- Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons
- (2012) Ji Won Um et al. NATURE NEUROSCIENCE
- Drug repositioning for Alzheimer's disease
- (2012) Anne Corbett et al. NATURE REVIEWS DRUG DISCOVERY
- Age-related declines in delayed non-match-to-sample performance (DNMS) are reversed by the novel 5HT6 receptor antagonist SB742457
- (2012) Charlotte K. Callaghan et al. NEUROPHARMACOLOGY
- Inhibition of acetylcholinesterase and phosphodiesterase-9A has differential effects on hippocampal early and late LTP
- (2012) Katja S. Kroker et al. NEUROPHARMACOLOGY
- Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease
- (2012) Robert Howard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
- (2012) Randall J. Bateman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apolipoprotein E genotypes and neuropsychiatric symptoms and syndromes in late-onset Alzheimer's disease
- (2011) Francesco Panza et al. AGEING RESEARCH REVIEWS
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment
- (2011) Suzanne Craft ARCHIVES OF NEUROLOGY
- 5-HT6 receptor and cognition
- (2011) Xabier Codony et al. CURRENT OPINION IN PHARMACOLOGY
- (Val8) glucagon-like peptide-1 prevents tau hyperphosphorylation, impairment of spatial learning and ultra-structural cellular damage induced by streptozotocin in rat brains
- (2011) Lin Li et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The Selective Phosphodiesterase 9 (PDE9) Inhibitor PF-04447943 Attenuates a Scopolamine-Induced Deficit in a Novel Rodent Attention Task
- (2011) Joshua D. Vardigan et al. JOURNAL OF NEUROGENETICS
- The Diabetes Drug Liraglutide Prevents Degenerative Processes in a Mouse Model of Alzheimer's Disease
- (2011) P. L. McClean et al. JOURNAL OF NEUROSCIENCE
- Novel GLP-1 mimetics developed to treat type 2 diabetes promote progenitor cell proliferation in the brain
- (2011) A. Hamilton et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Resolving controversies on the path to Alzheimer's therapeutics
- (2011) Dennis J Selkoe NATURE MEDICINE
- Allopregnanolone Promotes Regeneration and Reduces β-Amyloid Burden in a Preclinical Model of Alzheimer's Disease
- (2011) Shuhua Chen et al. PLoS One
- Exercise training increases size of hippocampus and improves memory
- (2011) K. I. Erickson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Brain renin-angiotensin—A new look at an old system
- (2011) John W. Wright et al. PROGRESS IN NEUROBIOLOGY
- The Discovery of VX-745: A Novel and Selective p38α Kinase Inhibitor
- (2011) John P. Duffy et al. ACS Medicinal Chemistry Letters
- Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease
- (2011) Randall J Bateman et al. Alzheimers Research & Therapy
- PF-04494700, an Oral Inhibitor of Receptor for Advanced Glycation End Products (RAGE), in Alzheimer Disease
- (2010) Marwan N. Sabbagh et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline
- (2010) Karin Yurko-Mauro et al. Alzheimers & Dementia
- Goal-Oriented Cognitive Rehabilitation for People With Early-Stage Alzheimer Disease: A Single-Blind Randomized Controlled Trial of Clinical Efficacy
- (2010) Linda Clare et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Effects of Aerobic Exercise on Mild Cognitive Impairment
- (2010) Laura D. Baker et al. ARCHIVES OF NEUROLOGY
- Double-Blind, Controlled Phase II Study of a 5-HT6 Receptor Antagonist, SB-742457, in Alzheimers Disease
- (2010) G. Maher-Edwards et al. Current Alzheimer Research
- Use of Antipsychotic Drugs in Patients with Alzheimerʼs Disease Treated with Rivastigmine versus Donepezil
- (2010) Douglas W. Scharre et al. DRUGS & AGING
- Lu AE58054, a 5-HT6 antagonist, reverses cognitive impairment induced by subchronic phencyclidine in a novel object recognition test in rats
- (2010) Jorn Arnt et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Docosahexaenoic Acid Supplementation and Cognitive Decline in Alzheimer Disease
- (2010) Joseph F. Quinn et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Anti-amnesic and neuroprotective potentials of the mixed muscarinic receptor/sigma1 (σ1) ligand ANAVEX2-73, a novel aminotetrahydrofuran derivative
- (2010) Vanessa Villard et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Putting brain training to the test
- (2010) Adrian M. Owen et al. NATURE
- Early-Stage Inflammation and Experimental Therapy in Transgenic Models of the Alzheimer-Like Amyloid Pathology
- (2010) A.C. Cuello et al. Neurodegenerative Diseases
- Val8-glucagon-like peptide-1 protects against Aβ1–40-induced impairment of hippocampal late-phase long-term potentiation and spatial learning in rats
- (2010) X.H. Wang et al. NEUROSCIENCE
- Allopregnanolone reverses neurogenic and cognitive deficits in mouse model of Alzheimer's disease
- (2010) J. M. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Protective Effects of Intranasal Losartan in the APP/PS1 Transgenic Mouse Model of Alzheimer Disease
- (2010) Lusine Danielyan et al. REJUVENATION RESEARCH
- M1 Agonists as a Potential Disease-Modifying Therapy for Alzheimers Disease
- (2009) Antonella Caccamo et al. Current Alzheimer Research
- Secretase inhibitors and modulators for Alzheimer’s disease treatment
- (2009) Taisuke Tomita Expert Review of Neurotherapeutics
- Neutralization of granulocyte macrophage colony-stimulating factor decreases amyloid beta 1-42 and suppresses microglial activity in a transgenic mouse model of Alzheimer's disease
- (2009) Maria Manczak et al. HUMAN MOLECULAR GENETICS
- Effect of Tarenflurbil on Cognitive Decline and Activities of Daily Living in Patients With Mild Alzheimer DiseaseA Randomized Controlled Trial
- (2009) Robert C. Green JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles
- (2009) Kamila B. Kurakhmaeva et al. JOURNAL OF DRUG TARGETING
- Cognitive Training for Early-Stage Alzheimer’s Disease and Dementia
- (2009) Fang Yu et al. Journal of Gerontological Nursing
- Memogain is a Galantamine Pro-drug having Dramatically Reduced Adverse Effects and Enhanced Efficacy
- (2009) Alfred Maelicke et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial
- (2009) Clive Ballard et al. LANCET NEUROLOGY
- Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease
- (2009) M. Blurton-Jones et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease
- (2009) J. Yao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Efficacy of a Vitamin/Nutriceutical Formulation for Moderate-stage to Later-stage Alzheimer's disease: A Placebo-controlled Pilot Study
- (2008) Ruth Remington et al. American Journal of Alzheimers Disease and Other Dementias
- Effect of Physical Activity on Cognitive Function in Older Adults at Risk for Alzheimer Disease
- (2008) Nicola T. Lautenschlager et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Site-Specific Blockade of RAGE-Vd Prevents Amyloid- Oligomer Neurotoxicity
- (2008) E. Sturchler et al. JOURNAL OF NEUROSCIENCE
- Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study
- (2008) Rachelle S Doody et al. LANCET
- Clearance mechanisms of Alzheimer's amyloid-β peptide: implications for therapeutic design and diagnostic tests
- (2008) K A Bates et al. MOLECULAR PSYCHIATRY
- Mitochondrial dysfunction: An early event in Alzheimer pathology accumulates with age in AD transgenic mice
- (2008) S. Hauptmann et al. NEUROBIOLOGY OF AGING
- The novel selective PDE9 inhibitor BAY 73-6691 improves learning and memory in rodents
- (2008) F. Josef van der Staay et al. NEUROPHARMACOLOGY
- 5-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer’s disease
- (2008) Neil Upton et al. Neurotherapeutics
- No Effect of One-Year Treatment with Indomethacin on Alzheimer's Disease Progression: A Randomized Controlled Trial
- (2008) Daniëlle de Jong et al. PLoS One
- Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms
- (2007) Yvonne Freund-Levi et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Hippocampal hypometabolism predicts cognitive decline from normal aging
- (2007) Lisa Mosconi et al. NEUROBIOLOGY OF AGING
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now